D.H.E. 45 Dosage
Generic name: Dihydroergotamine Mesylate 1mg in 1mL
Dosage form: injection, solution
Medically reviewed on November 6, 2017.
D.H.E. 45® (dihydroergotamine mesylate) Injection, USP should be administered in a dose of 1 mL intravenously, intramuscularly or subcutaneously. The dose can be repeated, as needed, at 1-hour intervals to a total dose of 3 mL for intramuscular or subcutaneous delivery or 2 mL for intravenous delivery in a 24-hour period. The total weekly dosage should not exceed 6 mL. D.H.E. 45® (dihydroergotamine mesylate) Injection, USP should not be used for chronic daily administration.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about D.H.E. 45 (dihydroergotamine)
- D.H.E. 45 Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 8 Reviews
- Generic Availability
- Drug class: antimigraine agents
Other brands: Migranal